Brendan Buckley MD, PhD
Non-Executive Director
Professor Brendan Buckley co-founded Open Orphan plc, a pharma services company focused on rare disease which he took public in 2019 whilst Chairman. He was also a co-founder of Minerva Medical Ltd, acquired by Quintiles and Firecrest Clinical Ltd, acquired by ICON plc where he held the position of Chief Medical Officer.
Professor Buckley was previously a Board member of the Health Products Regulatory Authority in Ireland and is currently non-executive director of a number of companies including Afimmune, DS Biopharma, Open Orphan and Imutex. Professor Buckley is presently serving as Chief Medical Officer of Teckro Ltd.
A medical graduate of University College Cork and a doctoral graduate in Biochemistry in the Faculty of Medicine at Oxford University, he worked for over 40 years in clinical practice as a Physician in endocrinology, diabetes and in academic clinical pharmacology. He is Honorary Clinical Professor at University College Cork and Adjunct Professor at University College Dublin in the respective medical faculties. He has published over 200 scientific papers, mainly on metabolic disease, as well as the recent key opinion-leading book ‘Re-Engineering Clinical Trials’.